Max Smock
Stock Analyst at William Blair
(1.24)
# 3,751
Out of 5,241 analysts
21
Total ratings
30.77%
Success rate
-8.5%
Average return
Main Sectors:
Stocks Rated by Max Smock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COR Cencora | Initiates: Market Perform | n/a | $257.71 | - | 1 | Apr 28, 2026 | |
| MCK McKesson | Initiates: Outperform | n/a | $760.57 | - | 1 | Apr 28, 2026 | |
| CAH Cardinal Health | Initiates: Outperform | n/a | $195.20 | - | 1 | Apr 28, 2026 | |
| SHC Sotera Health Company | Initiates: Outperform | n/a | $15.27 | - | 1 | Dec 18, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Outperform | n/a | $4.40 | - | 1 | May 21, 2025 | |
| MEDP Medpace Holdings | Downgrades: Market Perform | n/a | $415.27 | - | 4 | Apr 22, 2025 | |
| FTRE Fortrea Holdings | Reiterates: Market Perform | n/a | $13.66 | - | 5 | Mar 4, 2025 | |
| CRL Charles River Laboratories International | Downgrades: Market Perform | n/a | $150.85 | - | 2 | Jan 22, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | n/a | $116.38 | - | 1 | Jan 14, 2025 | |
| SLP Simulations Plus | Reiterates: Outperform | n/a | $13.34 | - | 4 | Nov 6, 2024 |
Cencora
Apr 28, 2026
Initiates: Market Perform
Price Target: n/a
Current: $257.71
Upside: -
McKesson
Apr 28, 2026
Initiates: Outperform
Price Target: n/a
Current: $760.57
Upside: -
Cardinal Health
Apr 28, 2026
Initiates: Outperform
Price Target: n/a
Current: $195.20
Upside: -
Sotera Health Company
Dec 18, 2025
Initiates: Outperform
Price Target: n/a
Current: $15.27
Upside: -
Lifecore Biomedical
May 21, 2025
Initiates: Outperform
Price Target: n/a
Current: $4.40
Upside: -
Medpace Holdings
Apr 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $415.27
Upside: -
Fortrea Holdings
Mar 4, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $13.66
Upside: -
Charles River Laboratories International
Jan 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $150.85
Upside: -
ICON Public Limited Company
Jan 14, 2025
Reiterates: Outperform
Price Target: n/a
Current: $116.38
Upside: -
Simulations Plus
Nov 6, 2024
Reiterates: Outperform
Price Target: n/a
Current: $13.34
Upside: -